Clinical Trial Update: Long Antagonist Protocol for IVF With Single Luteal Dose of Degarelix [Phase 3]

View source ↗

Summary

Phase 3 clinical trial updating the long antagonist protocol for IVF using a single luteal dose of degarelix.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pregnancy Ovarian

Drugs mentioned

• degarelix (degarelix)

Snippet

Sponsor: Assisting Nature | Conditions: Pregnancy, Ovarian | Phase 3 | Status: UNKNOWN